Canine cancer diagnoses can be devastating and demoralizing. While research and studies for human cancer have brought us a long way when it comes to treatment and instilling hope for our loved ones, the same can’t necessarily be said for the world of pet medicine. Despite this, there are many passionate veterinarians and veterinary oncologists out there who are helping to move the needle on pet cancer research and treatment. Taking cues from the progress made on human cancer treatment, FidoCure uses genomic testing to identify potential targeted therapies for their specific cancer profile. It also helps veterinarians and veterinary oncologists deduce effective therapies for future canine cancer cases. FidoCure has already shown that a prognosis can be enhanced through targeted therapies. Take hemangiosarcoma for instance…
